Vectalys
Chemicals & Related Products · France · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 Ave Du Président Kennedy, Saint-Germai...Phone Number
+33 139046880Website
www.vectalys.comRevenue
$6.6 MillionIndustry
ZI Rank: 1
About Vectalys
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Vectalys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Vectalys launches new products
Vectalys, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Vectalys had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Vectalys has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Vectalys recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Vectalys
Check out if Vectalys is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Vectalys has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Vectalys as Masked Content
Find 3 more new buyers
Vectalys Tech Stack
A closer look at the technologies used by Vectalys
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Vectalys
Vectalys is a Contract Development and Manufacturing Organization (CDMO) specializing in the production of lentiviral vectors, offering both non-integrative (LentiFlash) and integrative solutions from research and development to GMP grade. Their services cater to a range of applications including gene editing, immunotherapy, and stable cell line de... Read More
